Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Henk Reesink

1PUBLICATIONS
7CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Sep 01, 2021
Farnesoid X receptor agonist for the treatment of chronic hepatitis B: A safety study.

Robin Erken, Patrice Andre, Elise Roy

Pageof 1

Frequent Collaborators

1 joint publications

Robin Erken

1 joint publications

Patrice Andre

1 joint publications

Neeltje Kootstra

1 joint publications

Jacky Vonderscher

1 joint publications

Pietro Scalfaro

1 joint publications

Pisit Tangkijvanich

1 joint publications

Robert Flisiak

Frequent Collaborators

1 joint publications

Robin Erken

1 joint publications

Patrice Andre

1 joint publications

Neeltje Kootstra

1 joint publications

Jacky Vonderscher

Top Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

689
See more related videos

Top Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

689
See more related videos